BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38028219)

  • 1. Formulation of Glibenclamide proniosomes for oral administration: Pharmaceutical and pharmacodynamics evaluation.
    Alshora D; Ibrahim M; Alanazi N; Alowyid M; Ali Alnakhli Z; Mohammed Alshiban N; Maodaa S; Alyami NM; Alotaibi I
    Saudi Pharm J; 2023 Dec; 31(12):101830. PubMed ID: 38028219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration.
    Nasr M
    AAPS PharmSciTech; 2010 Mar; 11(1):85-9. PubMed ID: 20058106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
    Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W
    Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of proniosomes containing lornoxicam.
    Madan JR; Ghuge NP; Dua K
    Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proniosomal oral tablets for controlled delivery and enhanced pharmacokinetic properties of acemetacin.
    Shehata TM; Abdallah MH; Ibrahim MM
    AAPS PharmSciTech; 2015 Apr; 16(2):375-83. PubMed ID: 25319057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ niosome forming maltodextrin proniosomes of candesartan cilexetil: In vitro and in vivo evaluations.
    Yuksel N; Bayindir ZS; Aksakal E; Ozcelikay AT
    Int J Biol Macromol; 2016 Jan; 82():453-63. PubMed ID: 26455402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of Aceclofenac Proniosomes by Using Different Carriers, Part 1: Development and Characterization.
    Sammour RMF; Taher M; Chatterjee B; Shahiwala A; Mahmood S
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31323799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proniosomes as a Carrier System for Transdermal Delivery of Clozapine.
    Tareen FK; Shah KU; Ahmad N; Ur Rehman A; Shah SU; Ullah N
    Drug Dev Ind Pharm; 2020 May; ():1-24. PubMed ID: 32362194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the Bioavailability and Efficacy of Coenzyme Q10 on Alzheimer's Disease Through the Arginine Based Proniosomes.
    Ergin AD; Üner B; Balcı Ş; Demirbağ Ç; Benetti C; Oltulu Ç
    J Pharm Sci; 2023 Nov; 112(11):2921-2932. PubMed ID: 37506768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proniosome: A Promising Approach for Vesicular Drug Delivery.
    Ajrin M; Anjum F
    Turk J Pharm Sci; 2022 Aug; 19(4):462-475. PubMed ID: 36047601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Different Carriers on In Vitro and In Vivo Drug Release Behavior of Aceclofenac Proniosomes.
    Sammour RMF; Chatterjee B; Taher M; Saleh MSM; Shahiwala A
    Curr Drug Deliv; 2021; 18(9):1272-1279. PubMed ID: 33605859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced oral bioavailability of isradipine via proniosomal systems.
    Veerareddy PR; Bobbala SK
    Drug Dev Ind Pharm; 2013 Jun; 39(6):909-17. PubMed ID: 22998221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
    Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
    Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box-Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and
    Mujtaba MA; Kaleem M; Chaware R; Ingole A; Asiri YI; Hassan MZ; Sabale V; Sabale P; Anwer MK; Mahmood D; Aldawsari MF
    ACS Omega; 2024 Apr; 9(14):16346-16357. PubMed ID: 38617636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.
    Aboelwafa AA; El-Setouhy DA; Elmeshad AN
    AAPS PharmSciTech; 2010 Dec; 11(4):1591-602. PubMed ID: 21063815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
    Wen MM; Farid RM; Kassem AA
    J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of proniosomal glibenclamide formulation protects testicular tissue from hyperglycemia fluctuations and ROS via
    Alyami NM; Alnakhli ZA; Alshiban NM; Maodaa S; Almuhaini GA; Almeer R; Alshora D; Ibrahim M
    Heliyon; 2024 May; 10(10):e31283. PubMed ID: 38813164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Evaluation of Optimized Thiolated Chitosan Proniosomal Gel Containing Duloxetine for Intranasal Delivery.
    Khatoon M; Sohail MF; Shahnaz G; Ur Rehman F; Fakhar-Ud-Din ; Ur Rehman A; Ullah N; Amin U; Khan GM; Shah KU
    AAPS PharmSciTech; 2019 Aug; 20(7):288. PubMed ID: 31410741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol proniosomes as a convenient nanoingredient for functional food.
    Schlich M; Lai F; Pireddu R; Pini E; Ailuno G; Fadda AM; Valenti D; Sinico C
    Food Chem; 2020 Apr; 310():125950. PubMed ID: 31830712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology overview and drug delivery application of proniosome.
    Ahmad MZ; Mohammed AA; Mokhtar Ibrahim M
    Pharm Dev Technol; 2017 May; 22(3):302-311. PubMed ID: 26794727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.